Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Paul Senior who wrote (36943)	3/11/2010 5:16:32 PM
From: Madharry	Read Replies (1) \| Respond to of 78659

im curious. do you own this stuff in tax free accounts> if not doesnt the tax advantage of long term capital gains enter into your calculations?

To: Paul Senior who wrote (36943)	4/14/2010 1:34:55 PM
From: Paul Senior	Respond to of 78659

ABT. Have kept reducing my position, and now it's a stub. Company has good business history, good dividend history, and forward p/e (per Yahoo) for ABT is unusually low at about 11. Otoh, the stock hasn't done much in the past ten years to break out of a trading range: finance.yahoo.com Its humira drug accounts for $8m of ABT's $30M in rev. And the humira patent is in dispute (JNJ lawsuit), etc. Got to be better and/or safer places in the stock market at this time than with what should be a widow/orphan stock, ABT. Or perhaps it's just my fear factor that's rising.